Background--Radial artery occlusion (RAO) may occur posttransradial intervention and limits the radial artery as a future access site, thus precluding its use as an arterial conduit. In this study, we investigate the incidence and factors influencing the RAO in the current literature.
T ransradial access (TRA) has grown to become the default access site in the United Kingdom, [1] [2] [3] [4] Europe, and Asia 5 and is rapidly growing in the United States. [6] [7] [8] Compared with transfemoral access, TRA has been shown to reduce mortality and adverse cardiac events even in high-risk patient groups, 3, 9 reduces major bleeding and access site-related vascular complications 10 and patient discomfort, and allows early mobilization and reduced procedure-related costs. 11, 12 However, TRA is not without challenges and complications. TRA is technically more difficult with a longer learning curve and is associated with radial artery spasm and radial artery occlusion (RAO) particularly in females and elderly patients. 13, 14 RAO is a quiescent complication of TRA that rarely leads to critical hand ischemia requiring intervention because of the dual vascular supply of the hand from the palmar arch. RAO is often overlooked, and in fact more than 50% of operators do not even assess radial artery patency before discharge. 5 Once the radial artery is occluded, its future use as an access site for percutaneous coronary intervention (PCI), as a conduit for coronary bypass grafting, or fistula formation in hemodialysis patients is precluded. The reported incidence of RAO varies widely, from 0.8% to as high as 38% in the published data. [15] [16] [17] [18] [19] Studies have reported that baseline patient characteristics such as body mass index and diabetes may influence RAO. 20 A number of procedural variables such as sheath size, 21 use of anticoagulants, 17, 22 and patent hemostasis 17 have also been
shown to reduce the incidence of RAO.
Many studies have evaluated the incidence and risk factors for RAO, with several studies assessing interventions to reduce its likelihood. However, there has yet to be a systematic review that collectively synthesizes the evidence. We therefore conducted a systematic review with both pooled-and meta-analyses to investigate the incidence and factors influencing RAO in the TRA setting.
Methods
We searched MEDLINE and EMBASE in February 2015 using the broad search terms: ("radial occlusion" OR "radial artery occlusion") AND ("transradial" OR "radial catheterization" OR "radial artery catheterization" OR "radial catheterisation" OR "radial artery catheterisation"). The search results were reviewed by 2 independent investigators (C.S.K., M.R.) for studies that met the inclusion criteria and relevant reviews. Additional studies were retrieved by checking the bibliographies of included studies and relevant reviews.
We included primary studies that evaluated RAO. Studies were considered for detailed screening for inclusion if their abstract potentially met 1 of 3 criteria:
1. Primary studies with participants and evaluation of radial occlusion. 2. Any study that discusses RAO avoidance strategy. 3 . Any study that evaluates pharmacology, access site management, sheath and catheter types, radial artery diameter, and risk of radial occlusion.
We excluded studies that did not have results on RAO, but there was no restriction on the basis of types of interventions evaluated, language of study, or single-arm studies. We also excluded expert opinion and editorial reviews. We included conference abstracts or presentations in the hope of minimizing publication bias.
Data were extracted from each study into preformatted tables generated in Microsoft Word. The data collected were on the year, country, number of participants, age of participants, percentage of male participants, participant inclusion criteria, and type of interventions, follow-up assessment, results, and limitations. With regard to limitations, we documented whether the study was retrospective in nature or was only available in conference abstract form as well as if it was single arm or there was a large loss to follow-up.
On the basis of the availability of data, we synthesized the results using meta-analysis with quantitative pooling, graphically, or by narrative synthesis. Random effects meta-analysis was performed by the Mantel-Haenszel method for dichotomous data using RevMan 5.3 (Nordic Cochrane Centre, København, Denmark) in order to estimate pooled risk ratios. Statistical heterogeneity was assessed using I 2 statistic, with values of 30% to 60%, representing a moderate level of heterogeneity. 23 The method of pooling has been previously described. 24 In the final analysis, we excluded studies by the same research group over the same time period where there was the potential that the same participants were studied more than once. Where there were similar study participants, we chose the study with the largest sample size or highest adverse outcome event rate. We also performed sensitivity analysis to detect the incidence of RAO according to the starting year of the study, the completion year of the study, and type of procedure performed (ie, diagnostic coronary angiography versus PCI). We pooled the timings of the study according to whether the studies were performed prior to 2007, [2007] [2008] [2009] [2010] , and 2011 onwards.
Results
A total of 66 studies met the inclusion criteria. [15] [16] [17] [18] [19] [20] 22, The process of study selection is shown in Figure 1 . The details of the study design and participants are described in Table 1 . The included studies consisted of 9 retrospective cohort studies, 24 prospective cohort studies, 24 randomized studies, 2 matched/case-control studies, and 7 cohort studies. There were a total of 31 345 participants with a mean age of 64 years and 70% male reported by 48 studies. The study size varied from 27 participants 54 to the largest cohort of 7125. 81 The use of interventions, follow-up time, results, and study limitations are shown in Table 2 . Evaluation of RAO took place as soon as 2 to 3 hours after the procedure and as late as 507 days after the procedure. Twenty-five of the studies were only available in abstract or presentation form. Thirty-three studies reported RAO outcomes by using ultrasound assessment (Table 3 ).
The incidence of RAO reported by the included studies ranged from <1% to 33%, and we observed differences based on the timing of RAO evaluation ( Figure 2 ). Of the studies that evaluated RAO within 24 hours, 24 studies with 10 938 participants reported a RAO incidence of 7.7% (SD=4.23%, 95% CI AE0.08) ( Figure 3A ). Among 8 studies that assessed for RAO between 24 hours and 1 week, the combined results with 1377 participants was a RAO incidence of 9.5% (SD=3.69%, 95% CI AE0.19) ( Figure 3B ). For RAO evaluated >1 week follow-up, the combined results of 33 studies and 10 821 participants suggests that the RAO incidence was 5.56% (SD=5.19, 95% CI AE0.1) ( Figure 3C ). In our sensitivity analysis to detect the temporal incidence of RAO over time, we found a rising trend in incidence of RAO over time (P=0.02, for initiation year of study) (Table 4) . Additionally, we also found that the incidence of RAO during the diagnostic coronary angiogram setting was much higher at 8.8% compared to the 4.5% in PCI settings (P<0.001).
We found 14 trials that evaluated similar interventions that could be statistically pooled using meta-analysis* ( Figure 4 ). The only measure that significantly decreased RAO incidence was a higher dose of heparin (risk ratio 0.36; 95% CI 0.17-0.76). 30, 31, 42, 73 None of these studies reported increased bleeding risk with higher dose (5000 IU) of heparin. Another intervention shown to reduce RAO was the duration of We evaluated the incidence of RAO by size of catheter among 19 studies* ( Figure 5 ). We found a higher incidence of RAO with the increase in the size (outer diameter) of the catheter; however, the trend was not consistent among all studies, particularly studies evaluating 8-Fr size catheters, which consisted of a single study limited to 1 center. The incidence of RAO was 11% among 1297 participants in studies evaluating 6-Fr catheter, dropping markedly to 2% in 2662 participants in studies using 5-Fr catheter.
Several studies evaluated significant predictors of RAO* (Table 5) . Age was reported to be a significant predictor of RAO in 3 studies, 47, 77, 78 while sex was significant in 6 studies. 29, 49, 69, 73, 77, 78 Body weight was reported as a significant predictor in 3 studies. 17, 65, 75 In terms of procedural variables, use of a smaller introducer sheath has been shown to be predictive of lower RAO 71 and use of larger diameter of sheath 42, 78, 81 and duration of compression 61, 81 was associated with higher occlusion rates. Other predictors included baseline radial artery diameter, 19, 84, 85 peripheral artery disease, 79 statin use, 42 procedural success, 47 serum creatinine, 49 and heparin use. 66 Two studies evaluated the effectiveness of the TR band compared to other TRA hemostatic devices in reducing radial occlusion. 60, 67 Pancholy et al conducted a study of 500 patients and reported a statistically significant reduction in RAO with use of the TR band compared to HemoBand (4.4% versus 11.2%). 60 Rathore et al compared Radistop and TR band in 790 patients and found a nonsignificant reduction in RAO with TR band compared to Radistop (5.6% versus 8.0%, P=0.273).
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Several studies reported the influence of medications on RAO. Abboud et al reported an abstract where they showed that administration of a radial artery vasodilator cocktail before and after the procedure significantly reduced RAO compared to just before the procedure (0.5% versus 8%). 25 Ahmed et al conducted a study of participants with warfarin and reported higher incidences of RAO in the warfarin group compared to matched controls who received intraprocedural heparin. 26 Pancholy et al conducted a second study that compared administration of heparin after sheath insertion to no application of heparin unless postprocedure there was no radial patency and concluded that provisional use of heparin appears to be feasible and safe when patent hemostasis is maintained. 63 Plante et al compared bivalirudin and heparin and found no significant difference in RAO (3.5% bilvalirudin, 7.0% heparin), so they concluded that heparin should be preferred because its of low cost. 65 
Discussion
TRA has become the default access site for cardiac catheterization in many countries, and strategies to preserve the patency of the radial artery for future use are becoming an integral part of the catheterization procedure. Our analysis represents the first systematic review of such radial protection strategies, synthesizing evidence from over 66 studies and 31 345 participants, to assess the incidence of and risk factors for RAO as well as to examine the efficacy of the measures used to prevent it. Our analysis suggests that RAO is common, with incident rates of 7.7% for early RAO within 24 hours, declining to 5.5% at 1 month. Clinically, absence of radial pulse is often described as occluded artery; however, this can underestimate the true incidence of RAO. For example, in one study RAO incidence defined by absence of pulse was found to be 4.4%, whereas absence of radial artery flow was found to be at 10.5%. 16 It is therefore recommended to use a more objective method of assessment of RAO using radial flow as assessed by ultrasound. 86 In support of this, when studying the method of assessment of RAO, we observed that the incidence of RAO increased from 5.6% to 7.8% when ultrasound is used for detection of RAO. Many baseline patient characteristics such as sex, age, body mass index, and procedural variables such as artery-to-sheath ratio, heparin use, and duration of compression have been reported to be associated with RAO, but there appears to be a lot of heterogeneity in the literature. The incidence of RAO varies according to the timing of assessment of radial artery patency postprocedure. Acute RAO rates are higher acutely and decline with time. In the PROPHET study, the acute incidence of RAO (12%) was almost halved by the passage of 28 days (7%). 17 In accordance with these observations, our analysis also suggests a decreased incidence of RAO over a period of 28 days from 7.7% to 5.8%. This decline in the incidence of RAO with time can be explained by the spontaneous recanalization of the radial artery. Recanalization occurs as the results of activation of primary fibrinolysis. The damaged endothelium facilitates this by releasing tissue plasminogen activator and urokinase, thus allowing fibrinolysis to occur. TRA also negatively affects the structure and function of the radial artery, culminating in nonocclusive injury. 13 Endothelial and vascular smooth muscle integrity play a central role in preserving the function of the arterial wall. Damaged and dysfunctional endothelium has been strongly attributed to development of vascular disease and atherosclerosis. 87 More recently, changes in flow-mediated dilatation has been used as a surrogate of endothelial dysfunction. 88 Flow-mediated dilatation is an in vivo bioassay of NOmediated endothelial function in which vascular endothelium releases NO as a vasodilatory response according to the changes in the vascular blood flow. Yan et al recently demonstrated that average flow-mediated dilatation post 5-Fr TRA reduced significantly from 11.5% to 4.1% immediately after the procedure and dropped even further to 0.7% at 3 months. 89 This suggests that endothelial damage may actually persist longer than perceived. Additionally, TRA also results in structural damage to the radial artery. Yonetsu et al studied the structural changes in radial artery from acute vascular trauma and found that 67% of radial arteries had intimal tears and 36% had medial dissections immediately after transradial PCI. 90 The combination of these structural and functional changes in arterial wall lead to significant arterial remodeling, which may have important clinical implications. For instance, Sakai et al 91 studied patients undergoing repeated transradial interventions in the same arm and found that the rate of successful radial access decreases with successive procedures. Acute artery occlusion is thought to be a thrombotic phenomenon on a background of chronic occlusive changes. Sheath insertion and instrumentation during TRA causes endothelial damage, exposing the thrombogenic connective tissue. In addition, blood stasis while achieving hemostasis provides the nidus for thrombus formation. Therefore, reducing endothelial damage by minimizing compression time and using small introducer sheath size along with patent hemostasis may help in reducing the occlusion rates. Saito et al 21 studied the relationship between arterial blood flow and sheath size outer diameter and found that incidence of blood flow reduction is significantly low when radial artery inner diameter/cannulated sheath outer diameter is ≥1.0 (artery/sheath diameter ratio >1). In this study, although the incidence of severe flow reduction was low without any ischemic sequel, the incidence of RAO was not reported. We found that compression time of 15 minutes reduces RAO incidences significantly. 34, 66 Although the results were very promising and statistically significant, both of these studies were underpowered, with <200 patients in total in both arms (Figure 3) . Furthermore, Politi et al reported increased bleeding in patients subjected to shorter compression time in patent hemostasis settings. More recently, duration of compression (>4 hours versus <4 hours) was studied in a large randomized study by Dharma et al. They found that duration of compression alone was a strong predictor of RAO (odds ratio 3.11; 95% CI 1.62-5.82), supporting the hypothesis of minimizing radial injury by reducing compression time. Use of low molecular weight heparin (LMWH) is another routine practice to prevent thrombus formation and occlusive injury to the vessel by the mechanism as discussed above. In very early studies investigating the role of anticoagulants, Lefevre et al showed that the administration of heparin into the radial artery significantly reduced RAO. 92 Our results show that incidence of RAO increases by reducing the dose of intraarterial heparin ( Figure 5B ). We found that a heparin dose of 5000 IU was very effective in preserving the patency of radial artery when compared with lower doses of 2000 to 3000 IU (risk ratio 0.36 95% CI 0.17-0.76). No increased risk of bleeding was reported in the higher heparin arm. We also observed a lower rate of RAO in the PCI setting (4.5%) compared to the diagnostic coronary angiogram setting (8.8%), which may relate to routine use of dual antiplatelet therapy and anticoagulants such as heparin or bivalirudin during the PCI procedure. Other anticoagulants such bivalirudin and warfarin have also been studied as potential alternatives but did not show any significant benefit over LMWH; 64, 65 therefore, LMWH remains a preferred anticoagulant due to lower costs. Our finding resonates with the recommendation made by the Society for Cardiovascular Angiography and Interventions transradial working group, which advocates the use of 5000 IU heparin in all patients undergoing TRA. Since the inception of TRA, there have been numerous advances in catheter and sheath designs to facilitate the procedure and minimize the insult to the artery. We studied radial sheath length and coating and found no influence on RAO outcome. In a randomized trial of 790 compared long (23 cm) versus short (13 cm) sheaths and hydrophilic-coated or uncoated introducer sheaths, the authors found that neither sheath length nor coating affects RAO. 68 However, it has been suggested that using a small-diameter guide catheter may reduce the injury to radial artery and result in fewer occlusion rates. 52 This led to various innovations in the catheter design to minimize the outer diameter, including the development of sheathless guide catheters. Typically a 6-Fr sheathless guide catheter has an outer diameter that is smaller than that of a 5-Fr introducer sheath. We performed a pooled analysis to study the effect of various sizes (3, 4, 5, 6, 7, and 8 Fr) on incidence of RAO ( Figure 4 ). We observed that RAO rates increase with increasing size of guide catheter systems used. Although the size of the catheter seems to correlate with incidence of RAO in these studies, the overall results failed to show a statistically significant benefit between smaller and larger catheter sizes ( Figure 5A ). This may be because of under-representation of the smaller-size catheter in these studies (Figure 4) . Furthermore, a fair number of studies were single cohort studies undertaken without true randomization and may be subject to selection biases. In addition, there was no information available on the size (diameter) of radial artery in these studies, which may also explain the inconsistencies of relation of RAO to catheter size. Radial artery diameter and sheath-to-artery size ratio have been associated with better RAO outcomes. 21, 85 Nevertheless, the individual studies have shown promising results in reducing radial injury, supporting the hypothesis that small catheter size causes less radial artery trauma. Larger randomized studies with preprocedure ultrasonic assessment of radial artery diameter and sheath-to-artery ratio are required to show direct influence of catheter size on RAO. 
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Patient's baseline characteristics and procedural variables have been an area of interest to the researchers to predict occurrence of RAO (Table 4) . Age, sex, and body mass index have been investigated to predict RAO at the patient level while sheath-to-artery diameter, duration of compression, 34, 66 and anticoagulation 29, 30 have been studied as possible predictors of RAO. In our analysis, no factors were found to have consistent predictability of RAO among all the studies; however, age, sex, and body weight were most commonly reported predictors of RAO but there was no consistent direction of effect. For instance, 9 studies evaluated sex and 6 found that it was significant in predicting the RAO outcomes. Similarly, age was found to be a positive predictor in 3 of the 5 studies reporting on RAO. A more streamlined reporting of these variables in future trials may help in understanding the influences on RAO.
We also analyzed the effect of various pharmacological interventions in reducing RAO. In one study, administration of vasodilator cocktail in addition of to IV heparin before and after the procedure seems to have reduced the incidence of RAO. 25 Ahmed et al 26 also compared warfarin with LMWH to reduce RAO and concluded that warfarin was inferior to LMWH. In another prospective study, Zankl and colleagues 82 studied the efficacy of LMWH in treating the RAO postprocedure and found that LMWH significantly improved the recanalization rates of radial artery. These studies suggest that use of additional anticoagulation postprocedure may improve RAO outcome, but these studies were conducted without true randomization. Larger randomized studies are required to study the true effect of these medications in reducing RAO. Finally, Bernat et al 30 used a nonpharmacological novel intervention of compressing the ulnar artery postprocedure to increase the flow in radial artery once occluded. They found significantly lower rates of RAO post-ulnar artery compression and concluded that by doing so, flow through the radial artery increases, helping to reopen the artery postocclusion. Our study has several limitations. Many of the studies were included were single-arm studies for which we were only able to evaluate the incidence of RAO. We included conference abstracts to reduce publication bias, but quality assessment from these studies was poor because reporting of methods was brief. While we found sufficient studies with similar interventions for statistical pooling, many of the included studies were underpowered.
Conclusions
To our knowledge, this is first systematic review and metaanalysis to date studying the incidence of RAO and factors influencing RAO. We found the incidence of RAO overall was 7.7% up to 24 hours and 5.8% at up to 30 days, which is comparable with currently published literature. There was variation in the timing of assessment of RAO in many studies, and RAO rates decreased with time. Shorter compression time in a patent hemostasis setting and higher dose of heparin independently appear to reduce RAO. The relation of RAO to radial artery diameter needs to be evaluated in larger studies. Smaller sheath sizes have shown promising effects on reducing RAO in individual studies, but these results needs to replicated in larger randomized trials to show the true effect of sheath size. Furthermore, adequately powered trials are needed to confirm whether other interventions may reduce RAO. We studied the predictors and pharmacological treatments used to reduce RAO but found no consistency in the literature with better RAO outcomes.
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